Helius Medical Technologies, Inc. announced today that its flagship PoNS™ technology would be tested in a double-blind, randomized, sham-controlled pilot efficacy study in volunteer human subjects with a chronic balance deficit due to mild-to-moderate traumatic brain injury .
from Content Keyword RSS http://ift.tt/1uWj8P7
via IFTTT
from Content Keyword RSS http://ift.tt/1uWj8P7
via IFTTT
No comments:
Post a Comment